Clostri Shield BCDThis page contains information on Clostri Shield BCD for veterinary use.
The information provided typically includes the following:
- Clostri Shield BCD Indications
- Warnings and cautions for Clostri Shield BCD
- Direction and dosage information for Clostri Shield BCD
Clostri Shield BCDThis treatment applies to the following species:
Clostridium Perfringens Type C & D Bacterin-Toxoid
For Use In Animals Only
Clostri Shield BCD Indications
For use in healthy cattle and sheep as an aid in the prevention of enterotoxemia caused by Clostridium perfringens Types B, C, and D. Although Cl. perfringens Type B is not a significant problem in North America, the combination of Cl. Perfringens Type C (beta) and Type D (epsilon) fractions may protect against enterotoxemia caused by Cl. perfringens Type B.
ADJUVANT: Aluminum Hydroxide.
Directions For Use
Shake well before using. Cattle: Administer 2 mL intramuscularly in the neck. Repeat in 21 days. Sheep: Administer 1 mL intramuscularly. Repeat in 21 days. Revaccinate annually or as recommended by your veterinarian.
PrecautionsStore out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.
U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2007 Novartis; Registered trademark of Novartis AG
50 Cattle Doses
100 Sheep Doses
NAC No.: 1114010.7
Distributed by ELANCO ANIMAL HEALTH
2500 INNOVATION WAY, GREENFIELD, IN, 46140
|Small Animal Product Customer Service:||888-545-5973|
|Every effort has been made to ensure the accuracy of the Clostri Shield BCD information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-05-31